| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK 2193874 |
|---|
| Description | Potent and selective TRPV4 antagonist (IC50 values are 2 and 40 nM for rat and human receptors, respectively); inhibits Ca2+ influx through TRPV4 channels. Prevents and reverses pulmonary edema after myocardial infarction in vivo models. Selective over a panel of ~200 human receptors, channels and enzymes. Orally active. Purity 98%. MW (observed): 691.62 |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-([1,4'-Bipiperidin]-1'-ylmethyl)-7-bromo-N-(1-phenylcyclopropyl)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxamide |
|---|
| Gene, Accession, CAS # | CAS: 1336960-13-4 |
|---|
| Catalog # | 5106/5 |
|---|
| Price | |
|---|
| Order / More Info | GSK 2193874 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 26961876, 27191895 |
|---|
| 產(chǎn)品資料 |
|
|